Fibromyalgia as predictor of bad outcome after spinal injection
Research type
Research Study
Full title
Fibromyalgia Survey Score as an independent predictor of success following interventional pain procedures for patients with chronic non-cancer pain.
IRAS ID
231514
Contact name
Tomasz Bendinger
Contact email
Sponsor organisation
Sheffield Teaching Hospitals NHS Foundation Trust
Duration of Study in the UK
2 years, 0 months, 1 days
Research summary
All patients admitted to our Chronic Pain clinic with non-cancer pain undergo paper based psychological screening which assists multifactorial pain assessment. The screening test includes: BPI (Brief Pain Inventory), GAD (Generalized anxiety disorder), HADS (Hospital Anxiety and Depression Scale), PSEQ (Patient Self-Efficacy Questionnaire) and EuroQol EQ5D5L scale. Patients are referred for appropriate treatment after a physician’s assessment supported by the assessment measures as above. Currently, there are no single tools available with high predictive utility to guide clinical decision making with respect to needle based interventions in this area. A specific Fibromyalgia questionnaire (Fibromyalgia Survey Score) could provide useful information in this subgroup of patients - there are reports of its use for predicting outcomes in orthopaedic surgery and gynaecology surgery. Further interventional treatment is not going to be changed/influenced by this study. A positive outcome of the procedure is defined as a 50% reduction of pain score (assessed on Numeric Rating Scale) at 3 months. Statistical analysis will evaluate whether the Fibromyalgia Survey Score is a reliable predicting tool.
REC name
South West - Central Bristol Research Ethics Committee
REC reference
17/SW/0191
Date of REC Opinion
22 Aug 2017
REC opinion
Favourable Opinion